Rationale and design for the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) Trial.
Black HR, Elliott WJ, Neaton JD, Grandits G, Grambsch P, Grimm RH Jr, Hansson L, Lacoucière Y, Muller J, Sleight P, Weber MA, White WB, Williams G, Wittes J, Zanchetti A, Fakouhi TD.
Black HR, et al. Among authors: neaton jd.
Control Clin Trials. 1998 Aug;19(4):370-90. doi: 10.1016/s0197-2456(98)00013-0.
Control Clin Trials. 1998.
PMID: 9683312
Clinical Trial.